DTCAX
Price
$20.56
Change
+$0.10 (+0.49%)
Updated
Oct 17 closing price
Net Assets
504.59M
VSTSX
Price
$313.67
Change
+$1.37 (+0.44%)
Updated
Oct 17 closing price
Net Assets
2.02T
Interact to see
Advertisement

DTCAX vs VSTSX

Header iconDTCAX vs VSTSX Comparison
Open Charts DTCAX vs VSTSXBanner chart's image
BNY Mellon Sust US Equity A
Price$20.56
Change+$0.10 (+0.49%)
VolumeN/A
Net Assets504.59M
Vanguard Total Stock Mkt Idx Instl Sel
Price$313.67
Change+$1.37 (+0.44%)
VolumeN/A
Net Assets2.02T
DTCAX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
DTCAX vs. VSTSX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCAX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.02T vs. DTCAX (505M). VSTSX pays higher dividends than DTCAX: VSTSX (1.15) vs DTCAX (0.14). DTCAX was incepted earlier than VSTSX: DTCAX (26 years) vs VSTSX (9 years). DTCAX (0.98) is less costly to investors than VSTSX (0.01). DTCAX is a more actively managed with annual turnover of: 27.23 vs. VSTSX (2.00). DTCAX has a lower initial minimum investment than VSTSX: DTCAX (1000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 13.82 vs. DTCAX (4.36). VSTSX return over 5 years is better than : 85.01 vs. DTCAX (36.43).
DTCAXVSTSXDTCAX / VSTSX
Total Expense Ratio0.950.019,500%
Annual Report Gross Expense Ratio0.980.019,800%
Fund Existence26 years9 years-
Gain YTD12.53413.02996%
Front Load6%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets505M2.02T0%
Annual Yield % from dividends0.141.1513%
Returns for 1 year4.3613.8232%
Returns for 3 years41.8776.1655%
Returns for 5 years36.4385.0143%
Returns for 10 years59.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INDP3.700.27
+7.87%
Indaptus Therapeutics Inc
APPN28.150.36
+1.30%
Appian Corp
IONS73.090.02
+0.03%
Ionis Pharmaceuticals
LGO1.29-0.03
-2.27%
Largo
FDMT9.84-0.25
-2.48%
4D Molecular Therapeutics